Cargando…

Finding chemopreventatives to reduce amyloid beta in yeast

Detalles Bibliográficos
Autores principales:	Macreadie, Ian G., Arvanitis, Costa, Bharadwaj, Prashant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810986/ https://www.ncbi.nlm.nih.gov/pubmed/27073375 http://dx.doi.org/10.4103/1673-5374.177729

Ejemplares similares

Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
por: Dhakal, Sudip, et al.
Publicado: (2019)

A Toxic Synergy between Aluminium and Amyloid Beta in Yeast
por: Mcdonald, Jamieson B., et al.
Publicado: (2021)

Development of Convenient System for Detecting Yeast Cell Stress, Including That of Amyloid Beta
por: Luu, Yen Nhi, et al.
Publicado: (2018)

Gingers and Their Purified Components as Cancer Chemopreventative Agents
por: Lechner, John F., et al.
Publicado: (2019)

Red Beetroot and Betalains as Cancer Chemopreventative Agents
por: Lechner, John F., et al.
Publicado: (2019)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

Trans-Chalcone Plus Baicalein Synergistically Reduce Intracellular Amyloid Beta (Aβ(42)) and Protect from Aβ(42) Induced Oxidative Damage in Yeast Models of Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2021)

Targeting amyloid precursor protein shuttling and processing - long before amyloid beta formation
por: Arbor, Sage
Publicado: (2017)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Clearance of amyloid‐beta with bispecific antibody constructs bound to erythrocytes
por: Taylor, Ronald P., et al.
Publicado: (2020)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
por: Kwakowsky, Andrea, et al.
Publicado: (2020)

Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
por: Borse, Vikrant, et al.
Publicado: (2017)

Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system
por: Weaver, Donald F.
Publicado: (2020)

Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease
por: Richard, Edo, et al.
Publicado: (2021)

The tip of the iceberg? The underestimated potential of non-canonical beta-amyloids for Alzheimer’s disease
por: Busch, Lukas, et al.
Publicado: (2023)

Potent Skin Cancer Chemopreventing Activity of Some Novel Semi-synthetic Cembranoids from Marine Sources
por: Fahmy, Hesham, et al.
Publicado: (2006)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

The Use of Yeast in Biosensing
por: Dhakal, Sudip, et al.
Publicado: (2022)

Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APC(Min/+) Mouse Model of Intestinal Tumorigenesis
por: Paul-Clark, Mark, et al.
Publicado: (2016)

Galantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer's disease
por: Castillo, Willian O., et al.
Publicado: (2017)

Recent advancements toward non-invasive imaging of retinal amyloid-beta for early detection of Alzheimer’s disease
por: Wang, Liang, et al.
Publicado: (2022)

Beta‐amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease
por: Pannuzzo, Martina
Publicado: (2021)

Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention
por: Gopalakrishna, Rayudu, et al.
Publicado: (2023)

Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them
por: Fani, Giulia, et al.
Publicado: (2021)

Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
por: Wahle, Benjamin M., et al.
Publicado: (2017)

Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2020)

Radix et Rhizoma Ginseng chemoprevents both initiation and promotion of cutaneous carcinoma by enhancing cell-mediated immunity and maintaining redox homeostasis
por: Yu, Suyun, et al.
Publicado: (2020)

Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011)

Amyloid pores in mitochondrial membranes
por: Vassallo, Neville
Publicado: (2021)

Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
por: Bharadwaj, Prashant R, et al.
Publicado: (2009)

Breaking Up (Amyloid) Is Hard to Do
por: Gandy, Sam, et al.
Publicado: (2005)

Reconstructing the History of Yeast Genomes
por: Sankoff, David
Publicado: (2009)

Amyloid Precursor Protein (APP) and GABAergic Neurotransmission
por: Tang, Bor Luen
Publicado: (2019)

The biogenesis and biology of amyloid β oligomers in the brain
por: Ashe, Karen Hsiao
Publicado: (2020)

Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
por: Osborne, Olivia M., et al.
Publicado: (2023)

Transmission of amyloid-β pathology in humans: a perspective on clinical evidence
por: Catumbela, Celso S. G., et al.
Publicado: (2023)

Single-cell phenomics in budding yeast
por: Ohya, Yoshikazu, et al.
Publicado: (2015)

Forces that shape fission yeast cells
por: Chang, Fred
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i56nai7o7k132nl6i6q2ro7lhv